Your Article Summary
Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage
Clinical Cancer Research, 06/25/09
Mortarini R et al. - The results provide evidence for development of impaired STAT signaling in response to IL-2, along with clinical evolution of the disease, in melanoma patients' T cells.
Related Articles
Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
BMC Cancer, 12/09/09
Relevance Score: 47%
Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09
Relevance Score: 46%
State Uses Script Data to Track Flu
HealthDataManagement, 12/08/09
Relevance Score: 45%
Exploring three-year-old children in a primary child health care situation
Journal of Child Health Care, 12/07/09
Relevance Score: 45%
State Adoption of Nursing Home Pay-For-Performance
Medical Care Research and Review, 11/19/09
Relevance Score: 45%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters
Experimental and Clinical Endocrinology & Diabetes, 12/16/09
Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue
Oral Oncology , 12/16/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/16/09
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Human Pathology, 12/16/09
MK2 regulates the early stages of skin tumor promotion
Carcinogenesis, 12/16/09

See Latest Articles